139 related articles for article (PubMed ID: 10215192)
1. Lack of somatic mutation in the PTEN gene in squamous cell carcinomas of human skin.
Kubo Y; Urano Y; Hida Y; Arase S
J Dermatol Sci; 1999 Apr; 19(3):199-201. PubMed ID: 10215192
[TBL] [Abstract][Full Text] [Related]
2. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutation of PTEN in bladder carcinoma.
Aveyard JS; Skilleter A; Habuchi T; Knowles MA
Br J Cancer; 1999 May; 80(5-6):904-8. PubMed ID: 10360673
[TBL] [Abstract][Full Text] [Related]
4. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas.
Kurose K; Zhou XP; Araki T; Eng C
Genes Chromosomes Cancer; 2000 Oct; 29(2):166-72. PubMed ID: 10959096
[TBL] [Abstract][Full Text] [Related]
5. Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma.
Van Gele M; Leonard JH; Van Roy N; Cook AL; De Paepe A; Speleman F
Int J Cancer; 2001 May; 92(3):409-13. PubMed ID: 11291079
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma.
Feilotter HE; Coulon V; McVeigh JL; Boag AH; Dorion-Bonnet F; Duboué B; Latham WC; Eng C; Mulligan LM; Longy M
Br J Cancer; 1999 Feb; 79(5-6):718-23. PubMed ID: 10070859
[TBL] [Abstract][Full Text] [Related]
7. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
[TBL] [Abstract][Full Text] [Related]
8. The PTEN tumour suppressor gene and malignant melanoma.
Böni R; Vortmeyer AO; Burg G; Hofbauer G; Zhuang Z
Melanoma Res; 1998 Aug; 8(4):300-2. PubMed ID: 9764804
[TBL] [Abstract][Full Text] [Related]
9. Analysis of genetic and epigenetic alterations of the PTEN gene in gastric cancer.
Sato K; Tamura G; Tsuchiya T; Endoh Y; Sakata K; Motoyama T; Usuba O; Kimura W; Terashima M; Nishizuka S; Zou T; Meltzer SJ
Virchows Arch; 2002 Feb; 440(2):160-165. PubMed ID: 11964046
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the PTEN/MMAC1 gene in primary oesophageal squamous cell carcinomas.
Hu YC; Lam KY; Tang JC; Srivastava G
Mol Pathol; 1999 Dec; 52(6):353-6. PubMed ID: 10748870
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutation of PTEN in vulvar cancer.
Holway AH; Rieger-Christ KM; Miner WR; Cain JW; Dugan JM; Pezza JA; Silverman ML; Shapter A; McLellan R; Summerhayes IC
Clin Cancer Res; 2000 Aug; 6(8):3228-35. PubMed ID: 10955808
[TBL] [Abstract][Full Text] [Related]
13. Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head and neck, despite loss of heterozygosity at this locus.
Snaddon J; Parkinson EK; Craft JA; Bartholomew C; Fulton R
Br J Cancer; 2001 Jun; 84(12):1630-4. PubMed ID: 11401316
[TBL] [Abstract][Full Text] [Related]
14. Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas.
Reifenberger J; Wolter M; Boström J; Büschges R; Schulte KW; Megahed M; Ruzicka T; Reifenberger G
Virchows Arch; 2000 May; 436(5):487-93. PubMed ID: 10881743
[TBL] [Abstract][Full Text] [Related]
15. Allelic imbalance and mutations of the PTEN gene in ovarian cancer.
Saito M; Okamoto A; Kohno T; Takakura S; Shinozaki H; Isonishi S; Yasuhara T; Yoshimura T; Ohtake Y; Ochiai K; Yokota J; Tanaka T
Int J Cancer; 2000 Jan; 85(2):160-5. PubMed ID: 10629071
[TBL] [Abstract][Full Text] [Related]
16. Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors.
Halachmi N; Halachmi S; Evron E; Cairns P; Okami K; Saji M; Westra WH; Zeiger MA; Jen J; Sidransky D
Genes Chromosomes Cancer; 1998 Nov; 23(3):239-43. PubMed ID: 9790504
[TBL] [Abstract][Full Text] [Related]
17. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas.
Wang JY; Huang TJ; Chen FM; Hsieh MC; Lin SR; Hou MF; Hsieh JS
Virchows Arch; 2003 May; 442(5):437-43. PubMed ID: 12695913
[TBL] [Abstract][Full Text] [Related]
19. Allelic loss at 10q23.3 but lack of mutation of PTEN/MMAC1 in chromophobe renal cell carcinoma.
Sükösd F; Digon B; Fischer J; Pietsch T; Kovacs G
Cancer Genet Cytogenet; 2001 Jul; 128(2):161-3. PubMed ID: 11463457
[TBL] [Abstract][Full Text] [Related]
20. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.
Frisk T; Foukakis T; Dwight T; Lundberg J; Höög A; Wallin G; Eng C; Zedenius J; Larsson C
Genes Chromosomes Cancer; 2002 Sep; 35(1):74-80. PubMed ID: 12203792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]